- Dangote says asset sales, borrowing would boost reserves
The President of Dangote Group and Africa’s richest man, Alhaji Aliko Dangote, says Nigeria needs $15 billion from asset sales and borrowing to revive a slumping economy and boost foreign reserves.
“Through sales of assets, through loans from Bank of China or wherever, we need something like $15 billion,” Dangote, a Nigerian national, said in a Bloomberg TV interview at the U.S.-Africa Business Forum in New York on Wednesday. “We’re having a problem as the reserves are low. The banks, entrepreneurs, everybody is speculating on the currency.”
According to Bloomberg report, monitored by Business247 News Online, the West African country’s economy, battered by low oil prices and a dearth of foreign investment, is set to shrink in 2016 for the first time in 25 years, according to the International Monetary Fund, which forecasts a 1.8 percent contraction. Nigeria’s foreign reserves have fallen by more than a third since the end of September 2014 to a more than 10-year low of $24.8 billion. The naira has fallen almost 40 percent against the dollar this year.
President Muhammadu Buhari’s government is trying to spend a record budget of 6.1 trillion naira ($19.4 billion) to stimulate growth. The country plans to raise about $4.5 billion of concessional loans and Eurobonds this year to help pay for its spending plans.
Buhari, who came to power in May 2015, is making good on his promise to tackle corruption, said Dangote, who is worth $10.9 billion, according to Bloomberg Billionaires Index. The businessman, whose money is mostly tied up in Dangote Cement Plc, has lost $4.4 billion since the end of 2015, the fourth-most globally among billionaires, due in large part to the naira’s depreciation.
“President Buhari is doing a great job in terms of fighting corruption,” he said, without citing specific examples of the progress. “Corruption has gone down dramatically.”
Nigeria ranks among the world 40 most corrupt countries, according to Transparency International, the Berlin-based anti-graft body.